Medical Technology Company Heru, Inc. Completes FDA Registration Following a $2.7M Seed Round
Dec 21, 2020•over 4 years ago
Amount Raised
$2 Million
Round Type
seed
Description
Heru, a Bascom Palmer Eye Institute medical technology company developing a next-generation AI platform for vision diagnostics and augmentation, today announces its class I listing with the U.S. Food and Drug Administration (FDA) for its cloud-based augmented/virtual reality platform’s first diagnostic application for Visual Field Exams. Additionally, it closed a $2.7M seed investment round on June 15, 2020. The funding facilitates the completion of current clinical trials for FDA clearance of Heru’s wearable AI platform and subsequent commercialization efforts.